Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $25.82 Analyst target: $34.50 Upside: 33.62%
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company is headquartered in San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.